US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Ageas SA NV (FO4N) 銘柄情報

Ageas SA NV (FO4N)

66.90

0.00

(0.00%)

終了 6月12日 5:00AM

Ageas SA NV (FO4N) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

66.90

( - )

買値

66.75

売値

66.90

出来高

0.00

0.00 日の範囲 0.00

55.05 52 週間の範囲 69.35

時価総額

前日終値

66.90

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

346,212 €

発行済株式数

190,727,000

配当利回り

3.75 (5.58%)

PER

7.09

1 株当たり利益 (EPS)

9.09

歳入

9.43B

純利益

1.71B

ageas SA/NV, together with its subsidiaries, engages in insurance business. It operates through five segments: Belgium, Europe, Asia, Reinsurance, and General Account. The company provides property, casualty, and life insurance products, as well as pension products; and reinsurance products. It offe... ageas SA/NV, together with its subsidiaries, engages in insurance business. It operates through five segments: Belgium, Europe, Asia, Reinsurance, and General Account. The company provides property, casualty, and life insurance products, as well as pension products; and reinsurance products. It offers life insurance products include risks related to the life, and death of individuals; and non-life insurance products comprise accident and health, motor, and fire insurance products, as well as insurance services for other damages to property; and pension funds. The company serves private individuals, as well as small, medium-sized, and large companies through independent brokers and the bank channels. ageas SA/NV was founded in 1824 and is based in Brussels, Belgium. 詳細を表示

セクター

Finance

業界

Insurance

ウェブサイト

www.ageas.com

本社

Brussels, Belgium

設立

2026

Ageas SA NV is listed in the Finance sector of the Tradegate (DE) with ticker FO4N. The last closing price for Ageas SA NV was 66.90 €. Over the last year, Ageas SA NV shares have traded in a share price range of 55.05 € to 69.35 €.

Ageas SA NV currently has 190,727,000 shares in issue. The market capitalisation of Ageas SA NV is 12.76 € billion. Ageas SA NV has a price to earnings ratio (PE ratio) of 7.09.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	3.6	5.68720379147	63.3	66.75	62.8	670	64.50978806	DE
4	-0.85	-1.25461254613	67.75	69.349999	62.8	684	66.31929639	DE
12	6.1	10.0328947368	60.8	69.349999	57.7	862	65.88038826	DE
26	9.2	15.9445407279	57.7	69.349999	57.5	987	62.61784528	DE
52	10.05	17.6781002639	56.85	69.349999	55.05	886	60.63706217	DE
156	29.15	77.2185430464	37.75	69.349999	35.67	835	49.98062478	DE
260	20.4	43.8709677419	46.5	69.349999	34.1	642	49.37173469	DE

FO4N - Frequently Asked Questions (FAQ)

What is the current Ageas SA NV share price?

The current share price of Ageas SA NV is 66.90 €

How many Ageas SA NV shares are in issue?

Ageas SA NV has 190,727,000 shares in issue

What is the market cap of Ageas SA NV?

The market capitalisation of Ageas SA NV is EUR 12.76B

What is the 1 year trading range for Ageas SA NV share price?

Ageas SA NV has traded in the range of 55.05 € to 69.35 € during the past year

What is the PE ratio of Ageas SA NV?

The price to earnings ratio of Ageas SA NV is 7.09

What is the cash to sales ratio of Ageas SA NV?

The cash to sales ratio of Ageas SA NV is 1.3

What is the registered address of Ageas SA NV?

The registered address for Ageas SA NV is Manhattan Center, Brussels, Brussels, 1210

What is the Ageas SA NV website address?

The website address for Ageas SA NV is www.ageas.com

Which industry sector does Ageas SA NV operate in?

Ageas SA NV operates in the Insurance sector

Sleepy$$$

Sleepy$$$ 15分前

Outstanding Shares642,268,09705/29/2026Restricted625,012,64605/29/2026

Per otcmarkets.... float is tiny

Duke Knockem

Duke Knockem 17分前

I asked Belisarian holdings if they would take over Gs tickers, they didn't respond, but they 'liked' my post on Twitter. In 4 years it was only the second time they liked one of my post....🤷....to take with a grain of salt

nowwhat2

nowwhat2 21分前

STOP

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/netmygold_june_11_3m_daily_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https:/

nowwhat2

nowwhat2 22分前

STOP

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/netmygold_june_11_3m_daily_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https:/

axelvento

axelvento 22分前

Ovarian cancer CAR-T therapy, lira-cel, presentation to highlight positive survival observations from ongoing Phase 1 clinical trial

Breast cancer vaccine presentation to include final Phase 1 data showing all major primary endpoints were met and protocol-defined immune responses in 7

JohnnyRotton

JohnnyRotton 30分前

Wasn't to get sellers cause no one bought my sell order, cant get out now. Stuck. Just a small order.

jimr1717

jimr1717 31分前

I seriously doubt Nelson or Hawkins care who their marks are that they dump their shares on

ElectricDwarf15

ElectricDwarf15 34分前

Stuck short INHD after the T12 halt and looking to connect with anyone holding long shares who wants to exit.

I'm with Cobra DM me if interested.

knrorrel

knrorrel 35分前

$PAVD - It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dolla

ap17

Word on the street, the village Idiot, aka sims is going to change the traffic pattern. LMFAO
Don't forget! This about YOU! OUCH!!!
Might want to change that traffic pattern....so you can sit! LMFAO!!

https://www.instagram.com/p/DSS1QQ4EZk9/

Elon Musk: congratulations! Our country is lucky to have you…and you have excelled through hard work to help create the modern world more than anyone since Steve Jobs. You also are a father of many kids and are active in their lives. You have a great sense of humor and wit, and never before in histo

ace65

Up 100% ...excellent day with massive volume.
No complaints here.
Bought a chunk at .0004 and added .0005s.
Looking like .00s are coming.

knrorrel

knrorrel 40分前

It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dollar runner—

jour_trader

jour_trader 41分前

Valid question. Elite was up against a billion dollar organization known for dragging out patent protections time and time again. I think Elite and Accord’s cases brought to light the craziness of what Purdue was doing and perhaps the cases prevented further attempts at extending patents that the co

knrorrel

knrorrel 43分前

GM - watch $PAVS today, bid / ask moving higher 🚀

ddls

You know the stock is in trouble when even ddls's posts start thinning out.

Everyone's waiting for financials next year to see if any progress is being made here. Until then we should call BioElectronics Boring BIEL.

jour_trader

jour_trader 46分前

Yes, precisely. Now they can include with more certainty the financial value of Oxy in the DCF.

jour_trader

jour_trader 47分前

Nasrat will likely now be able to provide more clarification with case officially ending. Been a long road with a decent outcome. Eager to watch Accord to see what takes place with them and if they have first to file rights.

mrwrn2010

mrwrn2010 48分前

Saw that too. Possible M&A clause? 👀🧐🤔

ace65

WOW...just saw the eod Level II .WTF happened.
A high of .0037 million bought.

mrwrn2010

mrwrn2010 49分前

Even more reason to transfer full Adderall rights to Elite now. Methadone and Ropinirole alone ain’t gonna get us anywhere near the growth we need in the near term.

jour_trader

jour_trader 50分前

Also, #3 - should Elite sell or transfer ANDA…

mrwrn2010

mrwrn2010 50分前

It seems like Elite can amend the existing filing from a P IV to a P III if I’m reading the document correctly. So still, doesn’t make sense. Let us get the approval whenever and we’ll wait to launch as soon as those patents are up (assuming no one else has exclusivity).

Just give me $1.50

Just give me $1.50 53分前

Elite's attorneys are regarded, just like it's CEO.

We ain't launching Oxy until late 2028..........AT BEST.

jour_trader

jour_trader 54分前

I read that as submission to the FDA as in it buys Purdue even more time beyond the patent expiration date.

Meryllion Resources (PK)

Balanced Income Equity a...

Xtrackers IE Public

Ci Energy Giants Covered...

Industrie De Nora

Newday Funding Master Is...

Exchange Traded

Pursuit Minerals

Goldman Sachs Bank Usa C...

Robeco 3D European Equit...

ZCCM Investments (GM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。